Select for export The remarkable reimagining of psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14786419.2023.2272285 PubMed 37919964 Copy citation Copy BibTeX Natural Product Research 2023-11-01 Crist N. Filer OpenAlex Published psilocybin General Other More
Select for export Anxiolytic behavior accompanied by the alteration of the intestinal bacteriome during psilocybin treatment No abstract availability was recorded for this entry. Details DOI 10.1016/j.bbi.2024.01.164 Copy citation Copy BibTeX Brain Behavior and Immunity 2023-10-31 Emese Prandovszky, Zachary A. Cordner, Hua Liu, Megan Pedicini, Lindsey Macias, Kellie L. Tamashiro OpenAlex Published psilocybin Anxiety Other More
Select for export Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/rel14101312 Copy citation Copy BibTeX Religions 2023-10-18 Brian Macallan OpenAlex Published psilocybin AgingSpirituality Other More
Select for export Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/dep.2023.21 Copy citation Copy BibTeX Research Directions Depression 2023-10-12 Ian B. Hickie, Allan H. Young, F. Markus Leweke OpenAlex Published psilocybin DepressionPharmacologyTreatment-Resistant Depression Other More
Select for export Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future Abstract available at the source but not redistributed here. Read at source. Details DOI 10.48091/gsr.v3i2.62 Copy citation Copy BibTeX Georgetown Scientific Research Journal 2023-10-09 Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter OpenAlex Published psilocybin DepressionNeuroplasticityPharmacology Other More
Select for export Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2023.2268640 PubMed 37815125 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2023-10-09 Kiffer G. Card, Ashmita Grewal, Kalysha Closson, Gina Martin, Laura Baracaldo, Sandra Allison OpenAlex Published psilocybin PharmacologyObservational StudySafety Observational Study More
Select for export Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1159843 PubMed 37799400 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-09-19 Taylor Black OpenAlex Published psilocybin AddictionWellbeingSafety Other More
Select for export Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2023.00264 Copy citation Copy BibTeX Journal of Psychedelic Studies 2023-08-20 Benjamin M. Ross, James T. Neill OpenAlex Published psilocybin AnxietyReceptor PharmacologyPersonality Change Observational Study More
Select for export Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2023.2240322 PubMed 37605471 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2023-08-20 Joseph J. Palamar, Caroline Rutherford, Austin Le, Katherine M. Keyes OpenAlex Published psilocybin AddictionReceptor PharmacologyObservational Study Observational Study More
Select for export Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2023.09.9.20 Copy citation Copy BibTeX Psychiatric News 2023-08-14 Nick Zagorski OpenAlex Published psilocybin DepressionPTSDMechanism of Action Clinical Trial More
Select for export Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.abrep.2023.100513 PubMed 37649653 Copy citation Copy BibTeX Addictive Behaviors Reports 2023-08-10 Grant Jones, Felipe Herrmann, Erica Wang OpenAlex Published psilocybin Receptor PharmacologyObservational StudySafety Observational Study More
Select for export “Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-3189970/v1 Copy citation Copy BibTeX Research Square 2023-07-26 Finkelstein C, Soha O, Roy A, Phillipou A, Rossell S. Europe PMC PREPRINT (not peer reviewed) psilocybin Eating DisordersAgingSafety Other More
Select for export Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-3146433/v1 Copy citation Copy BibTeX Research Square 2023-07-19 Shahar O, Botvinnik A, Shwartz A, Lerer E, Buko A, Hamid E Europe PMC PREPRINT (not peer reviewed) psilocybin NeuroplasticityMechanism of ActionOxidative Stress Animal Study More
Select for export Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-3088850/v1 Copy citation Copy BibTeX Research Square 2023-07-17 Nkadimeng SM, Hay L, Steinmann CM, Eloff JN. Europe PMC PREPRINT (not peer reviewed) psilocybin Mechanism of ActionReceptor PharmacologyAnimal Study Animal Study More
Select for export Australia’s approval of MDMA and psilocybin for PTSD and depression is premature, say critics No abstract availability was recorded for this entry. Details DOI 10.1136/bmj.p1599 PubMed 37433614 Copy citation Copy BibTeX BMJ 2023-07-10 Bianca Nogrady OpenAlex Published psilocybin DepressionPTSD Other More
Select for export Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-3138705/v1 Copy citation Copy BibTeX Research Square 2023-07-06 Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H Europe PMC PREPRINT (not peer reviewed) psilocybinpsilocin DepressionAnxietyReceptor Pharmacology Animal Study More
Select for export Daily briefing: Australia will be first to prescribe these psychedelics as medicines No abstract availability was recorded for this entry. Details DOI 10.1038/d41586-023-02211-6 PubMed 37402900 Copy citation Copy BibTeX Nature 2023-06-29 Flora Graham OpenAlex Published psilocybin General Other More
Select for export Australia to prescribe MDMA and psilocybin for PTSD and depression in world first No abstract availability was recorded for this entry. Details DOI 10.1038/d41586-023-02093-8 PubMed 37386185 Copy citation Copy BibTeX Nature 2023-06-29 Rich Haridy OpenAlex Published psilocybin DepressionPTSDToxicity Other More
Select for export Psilocybin decelerates cellular senescence Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-2921423/v1 Copy citation Copy BibTeX Research Square 2023-06-26 Hecker L, kato k, Kleinhenz JMK, Shin Y, Papageorgiou J, Zarrabi A. Europe PMC PREPRINT (not peer reviewed) psilocybin Chronic PainMechanism of ActionBiomarkers In Vitro Study More
Select for export Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/add.16259 PubMed 37287110 Copy citation Copy BibTeX Addiction 2023-06-06 Katherine M. Keyes, Megan E. Patrick OpenAlex Published psilocybin Receptor PharmacologyObservational StudySafety Observational Study More